MedTrace Logo

Medical Record Study on Adverse Events Requiring a Higher Level of Care in Flemish Hospitals

NCT02044718 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 878

Last updated 2014-01-24

No results posted yet for this study

Summary

An adverse event (AE) is defined as unintended injury or complication, which results in disability, death or prolongation of hospital stay, and is caused by healthcare management (including omissions) rather than the patient's disease. Retrospective record reviews in several countries have shown that 2,9% to 16,6% of patients in acute hospitals experience one or more AEs. A patient with an AE may require a higher level of care. Although all AEs are important, preventable AEs that result in an upgraded level of patient care are of particular concern. In this study it's defined as an unplanned admission to intensive care unit (ICU) or a Mobile Emergency Team (MET) intervention. The objectives of this study are to determine the incidence of (preventable) adverse events requiring ICU admission or MET intervention and to assess the level of harm of each AE.

Conditions

  • Sepsis, Cancer, Heart Attack, Heart Failure, Abdominal Surgery, Trauma, Diabetes, Lung Disease, Gynaecology, Fertility, Cardiac Surgery,

Sponsors & Collaborators

  • Jessa Hospital

    collaborator OTHER

  • Algemeen Ziekenhuis Vesalius

    collaborator OTHER

  • Sint-Franciscus Ziekenhuis

    collaborator UNKNOWN

  • Regionaal Ziekenhuis Sint-Trudo

    collaborator UNKNOWN

  • Ziekenhuis Maas en Kempen

    collaborator OTHER

  • Ziekenhuis Oost-Limburg

    collaborator OTHER

  • Hasselt University

    lead OTHER

Principal Investigators

  • Kristel Marquet, drs · Hasselt University

  • Arthur Vleugels, prof. dr. · KU Leuven

Eligibility

Min Age
16 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-11-30
Primary Completion
2013-06-30
Completion
2013-06-30

Countries

  • Belgium

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02044718 on ClinicalTrials.gov